Carregant...

SUN-179 Prolonged Hypoglycemia from Insulin Degludec

Prolonged Hypoglycemia from Insulin Degludec Background:  Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Kothari, Vallari, Reutrakul, Sirimon
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553236/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-179
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!